Kestra Advisory Services »

Abcellera Biologics shares owned by Kestra Advisory Services

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Kestra Advisory Services from 13F filings

Historical chart of Kestra Advisory Services investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Kestra Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Kestra Advisory Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $36k 14k 2.60
2024-06-30 $32k 11k 2.96

More positions owned by Kestra Advisory Services

Apple (AAPL)
Parker-Hannifin Corporation (PH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)

View all positions for Kestra Advisory Services

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
BlackRock
Renaissance Technologies
Tang Capital Management
Federated Investors
Two Sigma Investments
Guardian Capital Advisors
Two Sigma Advisers
Citadel Advisors
Novo A/S

View all funds holding Abcellera Biologics